for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Marrone Bio Innovations Inc

MBII.OQ

Latest Trade

0.70USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.62

 - 

2.90

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.70
Open
--
Volume
--
3M AVG Volume
8.16
Today's High
--
Today's Low
--
52 Week High
2.90
52 Week Low
0.62
Shares Out (MIL)
177.15
Market Cap (MIL)
141.67
Forward P/E
-8.42
Dividend (Yield %)
--

Next Event

Q4 2021 Marrone Bio Innovations Inc Earnings Release

Latest Developments

More

Marrone Bio Innovations Inc - Q4 2021 Revenues Are Estimated To Reflect Growth In The Mid-30% Range Vs Q4 2020

Marrone Bio Innovations Posts Quarterly Loss Per Share Of 0.03

Marrone Bio Innovations QTRLY Loss Per Share $0.02

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Marrone Bio Innovations Inc

Marrone Bio Innovations, Inc. is an agricultural company that supports farming practices through the discovery, development and sale of biological products for crop protection, crop health and crop nutrition. The Company’s products include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate and Zelto. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. The Company’s markets include row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits, trees; nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentals and medicinal plants.

Industry

Chemical Manufacturing

Contact Info

1540 Drew Ave

DAVIS, CA

95618-6320

United States

+1.530.7502800

https://marronebio.com/

Executive Leadership

Robert A. Woods

Independent Chairman of the Board

Kevin R. Helash

Chief Executive Officer, Director

Suping Liu Cheung

Chief Financial Officer

Linda V. Moore

Executive Vice President, Chief Compliance Officer, General Counsel, Secretary

Amit Vasavada

Senior Vice President - Research and Development, Chief Technology Officer

Key Stats

2.00 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.0K
EPS (USD)

2018

-0.200

2019

-0.320

2020

-0.140

2021(E)

-0.092
Price To Earnings (TTM)
--
Price To Sales (TTM)
3.44
Price To Book (MRQ)
4.62
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
94.64
LT Debt To Equity (MRQ)
60.41
Return on Investment (TTM)
-29.75
Return on Equity (TTM)
-20.04

Latest News

Latest News

BRIEF-Marrone Bio Innovations Files For Resale Up To 152.6 Million Shares

* MARRONE BIO INNOVATIONS INC FILES FOR RESALE UP TO 152.6 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/3dsb2Js) Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up